Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

NCT00566137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-03-09

No results posted yet for this study

Summary

To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Conditions

  • Scleroderma
  • Pulmonary Hypertension

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Arunabh Talwar, MD · Northwell Health

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Completion
2007-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566137 on ClinicalTrials.gov